(Press-News.org) SAN FRANCISCO-Researchers have discovered a molecular switch that explains, at least in part, how some fast-growing prostate cancers become resistant to hormone treatment, a new study conducted in human cell cultures and mice finds. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
A factor not normally found in the prostate, called Steroidogenic Factor 1, stimulates production of new steroid hormones and increases cell multiplication to fuel growth of the tumor, researchers from the University of Wisconsin-Madison, found.
"This breakthrough exposes a potential biological marker and critical therapeutic target for the prevention or treatment of deadly prostate cancer," said the study's principal investigator, Joan Jorgensen, DVM, PhD.
Men with prostate cancer that has recurred or has spread outside the prostate routinely receive androgen deprivation therapy, which blocks the action of the male hormones and shrinks the tumor. This castration occurs with medications or, less often, through surgical removal of both testes, which make the steroid hormones. Although initially effective, this hormone-blocking treatment eventually stops working in most patients, and the cancer becomes deadly, Jorgensen said. This type of cancer is called castration-resistant prostate cancer.
Research evidence suggests that prostate cancer cells acquire the ability to produce their own steroids that promote the aggressive growth of the tumor, but the mechanism that causes this steroid synthesis was unclear, according to Jorgensen.
Steroidogenic Factor 1 is a transcription factor, or protein that binds to the genes. It is required for cell survival and cell proliferation during development and is necessary to stimulate steroid synthesis during development and in adulthood, Jorgensen said. Her group found that this factor is expressed in prostate cells only in samples of castration-resistant prostate cancer.
The group conducted several studies, which received funding from the University of Wisconsin-Madison Graduate School and a training grant from the National Institutes of Health. In one study, the researchers used a human cell line of an aggressive prostate cancer model. Cells with "knockdown," or repression, of Steroidogenic Factor 1 expression exhibited decreased steroid production and had problems with cell growth, compared with cancerous prostate cells with normal levels of the factor, the authors reported. When the investigators forced the expression of Steroidogenic Factor 1 in benign prostate cells, the result was increased steroid production and cell growth, she said.
Finally, 12 castrated male mice, which replicate the environment of a patient with treatment-resistant cancer, received transplants of the cultured human prostate cancer cells that were either normal (controls) or deficient in Steroidogenic Factor 1. The results showed that repressing Steroidogenic Factor 1 led to much smaller tumors than the controls had, Jorgensen said.
Steroidogenic Factor 1 likely is one of many molecular switches in the growth of castration-resistant prostate cancer, but Jorgensen said it appears to be an important one.
"This new knowledge eventually will enable us to design more personalized therapy regimens to attack aggressive castration-resistant prostate cancer using established treatments along with agents that block Steroidogenic Factor 1," she said.
###
Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter.
Source of tumor growth in aggressive prostate cancer found
2013-06-17
ELSE PRESS RELEASES FROM THIS DATE:
Excessive salt consumption appears to be bad for your bones
2013-06-17
SAN FRANCISCO-- A high-salt diet raises a woman's risk of breaking a bone after menopause, no matter what her bone density is, according to a new study that will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The Japanese study found that older women who consumed the highest amount of sodium had more than four times the risk of a nonvertebral fracture, or fracture at any site other than the spine. That finding held true even after the researchers made adjustments for many other characteristics that could affect fracture risk, said ...
Whole body vibration therapy increases bone strength
2013-06-17
SAN FRANCISCO-- A treatment known as whole body vibration therapy significantly increases bone strength among adolescents with cerebral palsy, a new clinical trial from New Zealand shows. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Cerebral palsy affects more than half a million people in the United States. Caused by brain damage around the time of birth, the disorder affects muscle tone and movement, which can severely decrease the quality of life by making walking and other daily activities difficult. As movement ...
Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
2013-06-17
A new osteoporosis drug hinders the growth of estrogen-sensitive cancer that has become resistant to treatment with tamoxifen, a study in mice shows. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
The medication, bazedoxifene, which is approved in Europe under the brand name Conbriza for the treatment and prevention of postmenopausal osteoporosis, also reduced estrogen activity and estrogen receptor levels in cultured human breast cancer cells, the study authors reported.
"Bazedoxifene, a known, safe drug approved ...
'Gene signature' test diagnoses benign thyroid growths
2013-06-17
A new genetic test accurately and consistently diagnoses benign growths, or nodules, on the thyroid gland, according to a study from Chile. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
"We have developed a 'gene signature' that effectively identifies benign thyroid nodules," said Hernan Gonzalez, MD, PhD, associate professor at the Pontifical Catholic University of Chile in Santiago. "This test is potentially useful to identify patients who do not require surgery."
The thyroid gland, located in the front of ...
Steroid hormone may be indicator of infant distress
2013-06-17
During labor and delivery, infants preferentially secrete a different stress hormone than their mothers do, according to a new clinical study. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco and published in the open access journal, PLoS One.
A primary component of good pregnancy care is the ability to quickly recognize and respond to fetal distress. Since the stress hormone cortisol is found in much higher concentrations than the hormone corticosterone, it has received greater attention as an indicator of stress ...
Dietary supplement linked to increased muscle mass in the elderly
2013-06-17
SAN FRANCISCO-- A supplemental beverage used to treat muscle-wasting may help boost muscle mass among the elderly, according to a new study. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
The supplemental beverage, called Juven®, contains three amino acids, including arginine. Amino acids are the building blocks of proteins, and are required for cell growth and repair. The amino acid arginine is especially important because it increases growth-hormone production, which causes the body to produce a critical protein called ...
Drugs used to treat heart failure and high blood pressure may help decrease obesity
2013-06-17
SAN FRANCISCO-- A type of drug normally used to treat heart failure and high blood pressure helped prevent weight gain and other complications related to a high-fat diet in an animal study. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
Weight gain, especially around the waist, and high blood pressure, combine with other abnormalities to form a cluster of diseases known as metabolic syndrome, which increases the risk of heart disease, diabetes and other serious illnesses. With obesity rates climbing in developed countries ...
Too little sleep may trigger the 'munchies' by raising levels of an appetite-controlling molecule
2013-06-17
SAN FRANCISCO--Insufficient sleep may contribute to weight gain and obesity by raising levels of a substance in the body that is a natural appetite stimulant, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
The researchers found that when healthy, lean, young adults received only 4.5 hours of sleep a night, they had higher daytime circulating, or blood, levels of a molecule that controls the pleasurable aspects of eating, compared with when they slept 8.5 hours.
"Past experimental studies show that ...
Weight loss improves memory and alters brain activity in overweight women
2013-06-17
SAN FRANCISCO-- Memory improves in older, overweight women after they lose weight by dieting, and their brain activity actually changes in the regions of the brain that are important for memory tasks, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.
"Our findings suggest that obesity-associated impairments in memory function are reversible, adding incentive for weight loss," said lead author Andreas Pettersson, MD, a PhD student at Umea University, Umea, Sweden.
Previous research has shown that obese ...
Being overweight linked to excess stress hormones after eating
2013-06-17
SAN FRANCISCO-- Overweight and obese men secrete greater amounts of stress hormones after eating, which may make them more susceptible to disease, a new observational study finds. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.
Excess weight and obesity are a global health problem, and medical researchers are seeking different approaches to reduce the burden of disease. One way to do this is by identifying differences in hormonal regulation between overweight and lean people in response to various situations, including ...